This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hammarskjöld, M L Articles by Simurda, M C Search for Related Content PubMed PubMed Citation Articles by Hammarskjöld, M L Articles by Simurda, M C

Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity.

Department of Microbiology, State University of New York, Buffalo 14214.

ABSTRACT

The Epstein-Barr virus latent membrane protein (LMP) is an integral membrane protein that is expressed in cells latently infected with the virus. LMP is believed to play an important role in Epstein-Barr virus transformation and has been shown to induce expression of several cellular proteins. We performed a series of experiments that demonstrated that LMP is an efficient transactivator of expression from the human immunodeficiency virus type 1 long terminal repeat (HIV-1 LTR). Mutation or deletion of the NF-kappa B elements in the LTR abolished the transactivation, indicating that the LMP effect on HIV expression was due to induction of NF-kappa B activity. Experiments in which the HIV-1 Tat protein was coexpressed in cells together with LMP showed that Tat was able to potentiate the transactivation. Surprisingly, a synergistic effect of the two proteins was observed even in the absence of the recognized target region for Tat (TAR) in the HIV-1 LTR.

This article has been cited by other articles:

• Lee, D. Y., Sugden, B. (2008). The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis. Blood 111: 2280-2289 [Abstract] [Full Text]  
• Sadagopan, S., Sharma-Walia, N., Veettil, M. V., Raghu, H., Sivakumar, R., Bottero, V., Chandran, B. (2007). Kaposi's Sarcoma-Associated Herpesvirus Induces Sustained NF-{kappa}B Activation during De Novo Infection of Primary Human Dermal Microvascular Endothelial Cells That Is Essential for Viral Gene Expression. J. Virol. 81: 3949-3968 [Abstract] [Full Text]  
• Soni, V., Yasui, T., Cahir-McFarland, E., Kieff, E. (2006). LMP1 Transmembrane Domain 1 and 2 (TM1-2) FWLY Mediates Intermolecular Interactions with TM3-6 To Activate NF-{kappa}B. J. Virol. 80: 10787-10793 [Abstract] [Full Text]  
• Brinkmann, M. M., Schulz, T. F. (2006). Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae.. J. Gen. Virol. 87: 1047-1074 [Abstract] [Full Text]  
• Yuan, J., Cahir-McFarland, E., Zhao, B., Kieff, E. (2006). Virus and Cell RNAs Expressed during Epstein-Barr Virus Replication. J. Virol. 80: 2548-2565 [Abstract] [Full Text]  
• Stevenson, D., Charalambous, C., Wilson, J. B. (2005). Epstein-Barr Virus Latent Membrane Protein 1 (CAO) Up-regulates VEGF and TGF{alpha} Concomitant with Hyperlasia, with Subsequent Up-regulation of p16 and MMP9. Cancer Res. 65: 8826-8835 [Abstract] [Full Text]  
• Grimm, T., Schneider, S., Naschberger, E., Huber, J., Guenzi, E., Kieser, A., Reitmeir, P., Schulz, T. F., Morris, C. A., Sturzl, M. (2005). EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX. Blood 105: 3263-3269 [Abstract] [Full Text]  
• Chimenti, C., Russo, A., Pieroni, M., Calabrese, F., Verardo, R., Thiene, G., Russo, M. A., Maseri, A., Frustaci, A. (2004). Intramyocyte Detection of Epstein-Barr Virus Genome by Laser Capture Microdissection in Patients With Inflammatory Cardiomyopathy. Circulation 110: 3534-3539 [Abstract] [Full Text]  
• Sutkowski, N., Chen, G., Calderon, G., Huber, B. T. (2004). Epstein-Barr Virus Latent Membrane Protein LMP-2A Is Sufficient for Transactivation of the Human Endogenous Retrovirus HERV-K18 Superantigen. J. Virol. 78: 7852-7860 [Abstract] [Full Text]  
• Lin, J.-C., Cherng, J.-M., Lin, H.-J., Tsang, C.-W., Liu, Y.-X., Lee, S. P. (2004). Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted 'epitope-loss variant'. J. Gen. Virol. 85: 2023-2034 [Abstract] [Full Text]  
• Yasui, T., Luftig, M., Soni, V., Kieff, E. (2004). Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling. Proc. Natl. Acad. Sci. USA 101: 278-283 [Abstract] [Full Text]  
• Saito, N., Courtois, G., Chiba, A., Yamamoto, N., Nitta, T., Hironaka, N., Rowe, M., Yamamoto, N., Yamaoka, S. (2003). Two Carboxyl-terminal Activation Regions of Epstein-Barr Virus Latent Membrane Protein 1 Activate NF-{kappa}B through Distinct Signaling Pathways in Fibroblast Cell Lines. J. Biol. Chem. 278: 46565-46575 [Abstract] [Full Text]  
• Dudziak, D., Kieser, A., Dirmeier, U., Nimmerjahn, F., Berchtold, S., Steinkasserer, A., Marschall, G., Hammerschmidt, W., Laux, G., Bornkamm, G. W. (2003). Latent Membrane Protein 1 of Epstein-Barr Virus Induces CD83 by the NF-{kappa}B Signaling Pathway. J. Virol. 77: 8290-8298 [Abstract] [Full Text]  
• Brown, H. J., Song, M. J., Deng, H., Wu, T.-T., Cheng, G., Sun, R. (2003). NF-{kappa}B Inhibits Gammaherpesvirus Lytic Replication. J. Virol. 77: 8532-8540 [Abstract] [Full Text]  
• Chen, H., Hutt-Fletcher, L., Cao, L., Hayward, S. D. (2003). A Positive Autoregulatory Loop of LMP1 Expression and STAT Activation in Epithelial Cells Latently Infected with Epstein-Barr Virus. J. Virol. 77: 4139-4148 [Abstract] [Full Text]  
• Chung, P.-J., Chang, Y.-S., Liang, C.-L., Meng, C.-L. (2002). Negative Regulation of Epstein-Barr Virus Latent Membrane Protein 1-mediated Functions by the Bone Morphogenetic Protein Receptor IA-binding Protein, BRAM1. J. Biol. Chem. 277: 39850-39857 [Abstract] [Full Text]  
• Carter, K. L., Cahir-McFarland, E., Kieff, E. (2002). Epstein-Barr Virus-Induced Changes in B-Lymphocyte Gene Expression. J. Virol. 76: 10427-10436 [Abstract] [Full Text]  
• Higuchi, M., Kieff, E., Izumi, K. M. (2002). The Epstein-Barr Virus Latent Membrane Protein 1 Putative Janus Kinase 3 (JAK3) Binding Domain Does Not Mediate JAK3 Association or Activation in B-Lymphoma or Lymphoblastoid Cell Lines. J. Virol. 76: 455-459 [Abstract] [Full Text]  
• Adler, B., Schaadt, E., Kempkes, B., Zimber-Strobl, U., Baier, B., Bornkamm, G. W. (2001). Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1. Proc. Natl. Acad. Sci. USA 10.1073/pnas.221439999v1 [Abstract] [Full Text]  
• Fielding, C. A., Sandvej, K., Mehl, A., Brennan, P., Jones, M., Rowe, M. (2001). Epstein-Barr Virus LMP-1 Natural Sequence Variants Differ in Their Potential To Activate Cellular Signaling Pathways. J. Virol. 75: 9129-9141 [Abstract] [Full Text]  
• Higuchi, M., Izumi, K. M., Kieff, E. (2001). Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: Protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc. Natl. Acad. Sci. USA 98: 4675-4680 [Abstract] [Full Text]  
• Höfelmayr, H., Strobl, L. J., Marschall, G., Bornkamm, G. W., Zimber-Strobl, U. (2001). Activated Notch1 Can Transiently Substitute for EBNA2 in the Maintenance of Proliferation of LMP1-Expressing Immortalized B Cells. J. Virol. 75: 2033-2040 [Abstract] [Full Text]  
• Sandberg, M. L., Kaykas, A., Sugden, B. (2000). Latent Membrane Protein 1 of Epstein-Barr Virus Inhibits as Well as Stimulates Gene Expression. J. Virol. 74: 9755-9761 [Abstract] [Full Text]  
• Flory, E., Kunz, M., Scheller, C., Jassoy, C., Stauber, R., Rapp, U. R., Ludwig, S. (2000). Influenza Virus-induced NF-kappa B-dependent Gene Expression Is Mediated by Overexpression of Viral Proteins and Involves Oxidative Radicals and Activation of Ikappa B Kinase. J. Biol. Chem. 275: 8307-8314 [Abstract] [Full Text]  
• Erickson, K. D., Martin, J. M. (2000). The Late Lytic LMP-1 Protein of Epstein-Barr Virus Can Negatively Regulate LMP-1 Signaling. J. Virol. 74: 1057-1060 [Abstract] [Full Text]  
• Bloss, T., Kaykas, A., Sugden, B. (1999). Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-{kappa}B activity. J. Gen. Virol. 80: 3227-3232 [Abstract] [Full Text]  
• Kaye, K. M., Izumi, K. M., Li, H., Johannsen, E., Davidson, D., Longnecker, R., Kieff, E. (1999). An Epstein-Barr Virus That Expresses Only the First 231 LMP1 Amino Acids Efficiently Initiates Primary B-Lymphocyte Growth Transformation. J. Virol. 73: 10525-10530 [Abstract] [Full Text]  
• Uchida, J., Yasui, T., Takaoka-Shichijo, Y., Muraoka, M., Kulwichit, W., Raab-Traub, N., Kikutani, H. (1999). Mimicry of CD40 Signals by Epstein-Barr Virus LMP1 in B Lymphocyte Responses. Science 286: 300-303 [Abstract] [Full Text]  
• Robek, M. D., Ratner, L. (1999). Immortalization of CD4+ and CD8+ T Lymphocytes by Human T-Cell Leukemia Virus Type 1 Tax Mutants Expressed in a Functional Molecular Clone. J. Virol. 73: 4856-4865 [Abstract] [Full Text]  
• Puls, A, Eliopoulos, A., Nobes, C., Bridges, T, Young, L., Hall, A (1999). Activation of the small GTPase Cdc42 by the inflammatory cytokines TNF(alpha) and IL-1, and by the Epstein-Barr virus transforming protein LMP1. J. Cell Sci. 112: 2983-2992 [Abstract]  
• Kulwichit, W., Edwards, R. H., Davenport, E. M., Baskar, J. F., Godfrey, V., Raab-Traub, N. (1998). Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc. Natl. Acad. Sci. USA 95: 11963-11968 [Abstract] [Full Text]  
• de Maisieres, P. D.-T., Baudoux-Tebache, L., Merville, M.-P., Rentier, B., Bours, V., Piette, J. (1998). Activation of the Human Immunodeficiency Virus Long Terminal Repeat by Varicella-zoster Virus IE4 Protein Requires Nuclear Factor-kappa B and Involves Both the Amino-terminal and the Carboxyl-terminal Cysteine-rich Region. J. Biol. Chem. 273: 13636-13644 [Abstract] [Full Text]  
• Liebowitz, D. (1998). Epstein-Barr Virus and a Cellular Signaling Pathway in Lymphomas from Immunosuppressed Patients. NEJM 338: 1413-1421 [Abstract] [Full Text]  
• Rickinson, A.B. (1998). Epstein-Barr Virus in Action in Vivo. NEJM 338: 1461-1463 [Full Text]  
• Johnson, R. J., Stack, M., Hazlewood, S. A., Jones, M., Blackmore, C. G., Hu, L.-F., Rowe, M. (1998). The 30-Base-Pair Deletion in Chinese Variants of the Epstein-Barr Virus LMP1 Gene Is Not the Major Effector of Functional Differences between Variant LMP1 Genes in Human Lymphocytes. J. Virol. 72: 4038-4048 [Abstract] [Full Text]  
• Miller, W. E., Cheshire, J. L., Raab-Traub, N. (1998). Interaction of Tumor Necrosis Factor Receptor-Associated Factor Signaling Proteins with the Latent Membrane Protein 1 PXQXT Motif Is Essential for Induction of Epidermal Growth Factor Receptor Expression. Mol. Cell. Biol. 18: 2835-2844 [Abstract] [Full Text]  
• Izumi, K. M., Kieff, E. D. (1997). The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappa B. Proc. Natl. Acad. Sci. USA 94: 12592-12597 [Abstract] [Full Text]  
• Brodeur, S. R., Cheng, G., Baltimore, D., Thorley-Lawson, D. A. (1997). Localization of the Major NF-kappa B-activating Site and the Sole TRAF3 Binding Site of LMP-1 Defines Two Distinct Signaling Motifs. J. Biol. Chem. 272: 19777-19784 [Abstract] [Full Text]  
• Izumi, K. M., Kaye, K. M., Kieff, E. D. (1997). The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 94: 1447-1452 [Abstract] [Full Text]  
• Mehl, A. M., Floettmann, J. E., Jones, M., Brennan, P., Rowe, M. (2001). Characterization of Intercellular Adhesion Molecule-1 Regulation by Epstein-Barr Virus-encoded Latent Membrane Protein-1 Identifies Pathways That Cooperate with Nuclear Factor kappa B to Activate Transcription. J. Biol. Chem. 276: 984-992 [Abstract] [Full Text]  
• Adler, B., Schaadt, E., Kempkes, B., Zimber-Strobl, U., Baier, B., Bornkamm, G. W. (2002). Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1. Proc. Natl. Acad. Sci. USA 99: 437-442 [Abstract] [Full Text]